Shandong Boan Biotechnology Co., Ltd.

HK$3.03As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6955Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 4Y CAGR (38.55%)
Div yield —
ROE (4.11%)
Biotechnology
Beta (5Y) 0.11
PE TTM —
TSR TTM (71.03%)
Mkt cap HK$1.886B
ROIC (1.52%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.93
(3.24%)
(15.07%)
Hold 0|12|11|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.04
0.04
0.04
9.56%
24.22%
17.02%
23.20%
Revenue¥M
131.7
128.5
130.2
136.4
2.91%
(0.57%)
(4.86%)
0.72%
Peers (US$240.5M)
Cap (US$)
PE
269.1M
179.9x
240.5M
10.86x
Capital
TTM
5Y
10Y
Leveragex
0.159
(1.318)
(1.174)
EBIT/Intx
0.392
0.319
0.309
Own earn%
(374.35)
(19.91)
(15.02)
Sh yield%
39.34
31.10
28.09
Owners
Insiders/Inst%
4.42
84.87
Short interest%
1.17
SBC / revenue%
3.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
21–29
$1 testx
—
Incr. ROIC%
9